{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:16:29Z","timestamp":1783455389653,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["R21 HL150487"],"award-info":[{"award-number":["R21 HL150487"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.contraception.2026.111399","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:44:46Z","timestamp":1769618686000},"page":"111399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patterns of hormonal contraception use in women with sickle cell disease and employer-sponsored insurance"],"prefix":"10.1016","volume":"160","author":[{"given":"Sarah H.","family":"O\u2019Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherraine L.","family":"Della-Moretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Stanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Creary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea H.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Bala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Vesely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose Y.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.contraception.2026.111399_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31683","article-title":"How we approach contraception for adolescents and young adults with sickle cell disease","volume":"72","author":"Leroy-Melamed","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.contraception.2026.111399_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.contraception.2021.08.009","article-title":"Contraceptive use and preferences among females with sickle cell disease","volume":"105","author":"Roe","year":"2022","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2026.111399_bib3","first-page":"552","article-title":"Women with sickle cell disease report low knowledge and use of long acting reversible contraception","volume":"113","author":"Pecker","year":"2021","journal-title":"J\u00a0Natl Med\u00a0Assoc"},{"issue":"3","key":"10.1016\/j.contraception.2026.111399_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1016\/j.contraception.2026.111399_bib5","article-title":"Progestin-only contraception is first line for sickle cell disease: a comment on \u201cHormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias","volume":"7","author":"Pecker","year":"2023","journal-title":"Res\u00a0Pract\u00a0Thromb\u00a0Haemos"},{"issue":"20","key":"10.1016\/j.contraception.2026.111399_bib6","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1182\/bloodadvances.2023010204","article-title":"Comparison of thromboembolism outcomes in patients with sickle cell disease prescribed hormonal contraception","volume":"7","author":"Bala","year":"2023","journal-title":"Blood Adv"},{"issue":"01","key":"10.1016\/j.contraception.2026.111399_bib7","first-page":"054","article-title":"Truven health analytics MarketScan databases for clinical research in colon and rectal surgery","volume":"32","author":"Kulaylat","year":"2019","journal-title":"Clin\u00a0Colon\u00a0Rect\u00a0Surg"},{"key":"10.1016\/j.contraception.2026.111399_bib8","unstructured":"Merative. [cited 2024 6\/5\/2024]; Available from: \u3008https:\/\/www.merative.com\/real-world-evidence\u3009."},{"key":"10.1016\/j.contraception.2026.111399_bib9","first-page":"1","article-title":"Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database","volume":"21","author":"Subramanya","year":"2021","journal-title":"BMC Cardiovasc\u00a0Disord"},{"issue":"3","key":"10.1016\/j.contraception.2026.111399_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/0033354919839072","article-title":"Improving an administrative case definition for longitudinal surveillance of sickle cell disease","volume":"134","author":"Snyder","year":"2019","journal-title":"Public Health Rep"},{"key":"10.1016\/j.contraception.2026.111399_bib11","article-title":"Evaluating the discriminatory ability of the sickle cell data collection program\u2019s administrative claims case definition in identifying adults with sickle cell disease: validation study","volume":"9","author":"Singh","year":"2023","journal-title":"JMIR Public Health\u00a0Surveill"},{"issue":"5","key":"10.1016\/j.contraception.2026.111399_bib12","first-page":"1550","article-title":"Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I\/II trial","volume":"94","author":"Kinney","year":"1999","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.contraception.2026.111399_bib13","first-page":"1317","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"issue":"2","key":"10.1016\/j.contraception.2026.111399_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/dc16-1534","article-title":"Hormonal contraception and risk of thromboembolism in women with diabetes","volume":"40","author":"O'Brien","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.contraception.2026.111399_bib15","unstructured":"Centers for Disease Control and Prevention. Key Statistics from the National Survey of Family Growth - C Listing. 2022 June 29, 2022; Available from: https:\/\/www.cdc.gov\/nchs\/nsfg\/key_statistics\/c-keystat.htm."},{"key":"10.1016\/j.contraception.2026.111399_bib16","article-title":"US selected practice recommendations for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR. Recommend\u00a0Rep"},{"key":"10.1016\/j.contraception.2026.111399_bib17","article-title":"US medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR. Recommend\u00a0Rep"},{"issue":"6","key":"10.1016\/j.contraception.2026.111399_bib18","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jadohealth.2021.06.008","article-title":"Provider attitudes, preferences, and practices regarding sexual and reproductive health for adolescents and young adults with sickle cell disease","volume":"69","author":"Leroy-Melamed","year":"2021","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.contraception.2026.111399_bib19","article-title":"Safety of hormonal contraception among women with sickle cell disease: an updated systematic review","author":"Nguyen","year":"2025","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2026.111399_bib20","doi-asserted-by":"crossref","first-page":"57 e1","DOI":"10.1016\/j.ajog.2017.03.005","article-title":"Continuation of copper and levonorgestrel intrauterine devices: a retrospective cohort study","volume":"217","author":"Phillips","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2026.111399_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/CEOR.S511996","article-title":"Clinical and economic burden of managing patients with sickle cell disease receiving frequent red blood cell transfusions in the United States","volume":"17","author":"Udeze","year":"2025","journal-title":"Clinicoecon Outcomes Res"},{"issue":"4","key":"10.1016\/j.contraception.2026.111399_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.29245\/2572-9411\/2017\/4.1124","article-title":"The accuracy of hospital ICD-9-CM codes for determining Sickle Cell Disease genotype","volume":"2","author":"Snyder","year":"2017","journal-title":"J Rare Dis Res Treat"},{"issue":"5","key":"10.1016\/j.contraception.2026.111399_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/pbc.25432","article-title":"The accuracy of using ICD\u20109\u2013CM codes to determine genotype and fever status of patients with sickle cell disease","volume":"62","author":"Eisenbrown","year":"2015","journal-title":"Pediatri. Blood Cancer"},{"issue":"2","key":"10.1016\/j.contraception.2026.111399_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.54552","article-title":"Severe maternal morbidity and mortality in sickle cell disease in the National Inpatient Sample, 2012-2018","volume":"6","author":"Early","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.contraception.2026.111399_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jfprhc-2013-100763","article-title":"Trends in family planning and counselling for women with sickle cell disease in the UK over two decades","volume":"41","author":"Eissa","year":"2015","journal-title":"J Fam Plann Reprod Health Care"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782426000363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782426000363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T19:43:02Z","timestamp":1783453382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782426000363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":25,"alternative-id":["S0010782426000363"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2026.111399","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of hormonal contraception use in women with sickle cell disease and employer-sponsored insurance","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2026.111399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111399"}}